231 related articles for article (PubMed ID: 21273057)
21. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
Alemayehu A; Sebova K; Fridrichova I
Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
[TBL] [Abstract][Full Text] [Related]
22. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
23. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
[TBL] [Abstract][Full Text] [Related]
24. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA
Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000
[TBL] [Abstract][Full Text] [Related]
25. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.
Walsh MD; Cummings MC; Buchanan DD; Dambacher WM; Arnold S; McKeone D; Byrnes R; Barker MA; Leggett BA; Gattas M; Jass JR; Spurdle AB; Young J; Obermair A
Clin Cancer Res; 2008 Mar; 14(6):1692-700. PubMed ID: 18310315
[TBL] [Abstract][Full Text] [Related]
26. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
27. Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test.
Schofield L; Watson N; Grieu F; Li WQ; Zeps N; Harvey J; Stewart C; Abdo M; Goldblatt J; Iacopetta B
Int J Cancer; 2009 Mar; 124(5):1097-102. PubMed ID: 19072991
[TBL] [Abstract][Full Text] [Related]
28. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.
Mensenkamp AR; Vogelaar IP; van Zelst-Stams WA; Goossens M; Ouchene H; Hendriks-Cornelissen SJ; Kwint MP; Hoogerbrugge N; Nagtegaal ID; Ligtenberg MJ
Gastroenterology; 2014 Mar; 146(3):643-646.e8. PubMed ID: 24333619
[TBL] [Abstract][Full Text] [Related]
29. Population-based screening for Lynch syndrome in Western Australia.
Schofield L; Grieu F; Amanuel B; Carrello A; Spagnolo D; Kiraly C; Pachter N; Goldblatt J; Platell C; Levitt M; Stewart C; Salama P; Ee H; Raftopoulous S; Katris P; Threlfall T; Edkins E; Wallace M; Iacopetta B
Int J Cancer; 2014 Sep; 135(5):1085-91. PubMed ID: 24474394
[TBL] [Abstract][Full Text] [Related]
30. Identifying Lynch syndrome: we are all responsible.
Sanchez JA; Vogel JD; Kalady MF; Bronner MP; Skacel M; Church JM
Dis Colon Rectum; 2008 Dec; 51(12):1750-6. PubMed ID: 18682882
[TBL] [Abstract][Full Text] [Related]
31. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
[TBL] [Abstract][Full Text] [Related]
32. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.
Vilar E; Mork ME; Cuddy A; Borras E; Bannon SA; Taggart MW; Ying J; Broaddus RR; Luthra R; Rodriguez-Bigas MA; Lynch PM; You YQ
Cancer Genet; 2014; 207(10-12):495-502. PubMed ID: 25432668
[TBL] [Abstract][Full Text] [Related]
33. Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer.
Overbeek LI; Kets CM; Hebeda KM; Bodmer D; van der Looij E; Willems R; Goossens M; Arts N; Brunner HG; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Br J Cancer; 2007 May; 96(10):1605-12. PubMed ID: 17453009
[TBL] [Abstract][Full Text] [Related]
34. [Recognition of congenital endometrial carcinoma: the importance of family history and investigation of microsatellite instability in the tumour].
Hoogerbrugge N; Overbeek LI; de Hullu J; Kets CM; Hebeda KM; Ligtenberg MJ
Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1441-4. PubMed ID: 17633970
[TBL] [Abstract][Full Text] [Related]
35. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.
Heald B; Plesec T; Liu X; Pai R; Patil D; Moline J; Sharp RR; Burke CA; Kalady MF; Church J; Eng C
J Clin Oncol; 2013 Apr; 31(10):1336-40. PubMed ID: 23401454
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemical expression and microsatellite instability in Lynch syndrome].
Vaccaro CA; Carrozzo JE; Mocetti E; Berho M; Valdemoros P; Mullen E; Oviedo M; Redal MA
Medicina (B Aires); 2007; 67(3):274-8. PubMed ID: 17628916
[TBL] [Abstract][Full Text] [Related]
37. [Lynch syndrome in the hands of pathologists].
Daum O; Beneš Z; Hadravský L; Stehlík J; Cerná K; Dušek M; Kokošková B; Michal M
Cesk Patol; 2014 Jan; 50(1):18-24. PubMed ID: 24624982
[TBL] [Abstract][Full Text] [Related]
38. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
Kravochuck SE; Church JM
ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
[TBL] [Abstract][Full Text] [Related]
39. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer.
Siraj AK; Prabhakaran S; Bavi P; Bu R; Beg S; Hazmi MA; Al-Rasheed M; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS
Cancer; 2015 Jun; 121(11):1762-71. PubMed ID: 25712738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
